Point72 Asset Management’s Fusion Pharmaceuticals FUSN Stock Holding History
Bought
Maintained
Sold
Other funds holding FUSN
Point72 Asset Management's FUSN Position: Q1 2024 in Review
Point72 Asset Management sold out of Fusion Pharmaceuticals (FUSN) in Q1 2024, closing a stake of 293,611 shares — an estimated $2.82M sold.
Point72 Asset Management first reported a position in FUSN in Q2 2020 and held it in 14 quarters. The position peaked at $8.04M in Q1 2021. 114 funds tracked by Wall St. Rank hold FUSN as of Q1 2024.
- Point72 Asset Management reported no remaining Fusion Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
- Point72 Asset Management sold 293,611 Fusion Pharmaceuticals shares in Q1 2024, an estimated $2.82M.
- Point72 Asset Management first reported a position in Fusion Pharmaceuticals in Q2 2020 and held it in 14 quarters.
- Point72 Asset Management's Fusion Pharmaceuticals position peaked at $8.04M in Q1 2021.
- 114 funds tracked by Wall St. Rank held Fusion Pharmaceuticals as of Q1 2024.
Based on Point72 Asset Management's 13F filing for Q1 2024, filed 15 May 2024.